A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning
Biology of Blood and Marrow Transplantation2016Vol. 23(1), pp. 38–43
Citations Over TimeTop 10% of 2016 papers
Michael Scordo, Valkal Bhatt, Meier Hsu, Antonio Omuro, Matthew J. Matasar, Lisa M. DeAngelis, Parastoo B. Dahi, Craig H. Moskowitz, Sergio Giralt, Craig S. Sauter
Related Papers
- → A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning(2016)27 cited
- → Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation(2020)7 cited
- A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.(1994)
- → Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis(2023)1 cited
- → Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation(2005)